Kyntra Bio, Inc. KYNB
1.56 USD -0.24 (-13.33%)
Regular-session close
1.56 0.00 0.00%
After hours · Nov 20, 4:00 PM ET
1.56 Day range 1.81
1.56 52-week range 10.04
- YTD
- -82.23%
- 1 year
- -81.20%
5D -1.55 (-42.94%)
- Market cap
- 6.32M
- EPS (ttm)
- -4.35
- YTD return
- -82.23%
- 1-year return
- -81.20%
- Volume
- 37.38K
- Avg volume
- 30.00K
- Open
- 1.81
- Previous close
- 1.80
- Day's range
- 1.56 – 1.81
- 52-week range
- 1.56 – 10.04
Fundamental scorecard
5 of 25 checks passed on KYNB’s reported financials
5of 25 checks passed
- Value 1 of 5
- Growth 1 of 5
- Profitability 0 of 5
- Financial health 3 of 5
- Dividend 0 of 5
Statements to Sep 30, 2026.
Financials — quick view
KYNB Revenue — quarterly 1.76M
KYNB Net income — quarterly 157.00K
KYNB EPS — quarterly 0.04
News
Kyntra Bio, Inc. (KYNB) Q3 2026 Earnings Call Transcript Lake Street Maintains Buy on Kyntra Bio, Lowers Price Target to $8
12 Health Care Stocks Moving In Tuesday's Intraday Session Oppenheimer Maintains Outperform on Kyntra Bio, Lowers Price Target to $30
HC Wainwright & Co. Maintains Buy on Kyntra Bio, Lowers Price Target to $18
Kyntra Bio (KYNB) Reports Q3 Loss, Misses Revenue Estimates Update: Kyntra Bio Q3 Adj. EPS $(3.42) Beats $(3.55) Estimate, Sales $1.762M Miss $1.766M Estimate
Kyntra Bio Reports Third Quarter 2026 Financial Results and Provides Business Update
Your note
Sign in to keep a note on KYNB — it syncs with the Stock Master app.
